mlsanityData to 7 Oct 2026

Continuous Treatment Effects with Surrogate Outcomes

arXiv 2402.00168 ↗First posted 31 Jan 2024stat.ML cs.LG stat.MEcited by 1

Not on the map. Why?

Abstract (arXiv)

In many real-world causal inference applications, the primary outcomes (labels) are often partially missing, especially if they are expensive or difficult to collect. If the missingness depends on covariates (i.e., missingness is not completely at random), analyses based on fully observed samples alone may be biased. Incorporating surrogates, which are fully observed post-treatment variables related to the primary outcome, can improve estimation in this case. In this paper, we study the role of surrogates in estimating continuous treatment effects and propose a doubly robust method to efficiently incorporate surrogates in the analysis, which uses both labeled and unlabeled data and does not suffer from the above selection bias problem. Importantly, we establish the asymptotic normality of the proposed estimator and show possible improvements on the variance compared with methods that solely use labeled data. Extensive simulations show our methods enjoy appealing empirical performance.

Key facts. Cited by 1 paper in the map (data through 7 Oct 2026). Builds on 15 of its 57 references that are in the map. First posted on arXiv 31 Jan 2024.

Builds on

15 of 57 references.

References · 15

  1. 2022Semiparametric doubly robust targeted double machine learning: a reviewcited by 129
  2. 2015Nonparametric methods for doubly robust estimation of continuous treatment effectscited by 62
  3. 2020On the role of surrogates in the efficient estimation of treatment effects with limited outcome datacited by 36
  4. 2017Generalizing causal inferences from individuals in randomized trials to all trial-eligible individualscited by 24
  5. 2018Sharp instruments for classifying compliers and generalizing causal effectscited by 22
  6. 2023Covariate-assisted bounds on causal effects with instrumental variablescited by 10
  7. 2022A General Framework for Treatment Effect Estimation in Semi-Supervised and High Dimensional Settingscited by 8
  8. 2022Fast convergence rates for dose-response estimationcited by 8
  9. 2016Estimating scaled treatment effects with multiple outcomescited by 7
  10. 2022Debiased inference for a covariate-adjusted regression functioncited by 5
  11. 2021Nested Nonparametric Instrumental Variable Regressioncited by 4
  12. 2022Kernel methods for long term dose response curvescited by 4
3 more
  1. 2023Efficient Generalization and Transportationcited by 4
  2. 2023Flexibly Estimating and Interpreting Heterogeneous Treatment Effects of Laparoscopic Surgery for Cholecystitis Patientscited by 2
  3. 2021Efficient and Robust Semi-supervised Estimation of ATE with Partially Annotated Treatment and Responsecited by 1

Built on by

Cited by year

Citing papers per year: 2024: 1.

1 paper.